Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Cascade Chemistry selected to help speed clinical testing of promising investigational drug for COVID-19

Cascade Chemistry, a leading contract research and manufacturing organization serving the pharmaceutical, materials, and chemical industries, today announced that it has been selected to produce the active pharmaceutical ingredient for clinical trial supplies of RBT-9, an investigational therapy entering a Phase 2 trial for the treatment of COVID-19 patients who are at high risk of deteriorating health due to age or comorbid conditions such as kidney or cardiovascular disease.

16 Jun 2020

Genetic marker may predispose African Americans to cardiac complications from COVID-19

Nearly one out of every 10 African Americans has a genetic variant that puts them inherently at an increased risk for ventricular arrhythmias and sudden cardiac death.

15 Jun 2020

Common cholesterol-lowering drug linked to improvement in gut microbiota

There is a clear link between improved gut microbiota and one of our most common cholesterol-lowering drug groups: statins.

15 Jun 2020

Vitamin K may offer protective health benefits as we age, study suggests

A new, multi-ethnic study found older adults with low vitamin K levels were more likely to die within 13 years compared to those whose vitamin K levels were adequate.

15 Jun 2020

Study finds link between high levels of dietary AGEs and breast cancer risk

Hollings Cancer Center researchers at the Medical University of South Carolina and colleagues assessed the connection between dietary advanced glycation end products and breast cancer risk in a study first published online March 2020 in Cancer Prevention Research.

12 Jun 2020

Does COVID-19 injure the placenta of pregnant women?

News-Medical speaks to Dr. Jeffery Goldstein about whether COVID-19 is damaging the placentas of pregnant women and what women can do to protect themselves.

12 Jun 2020

Race-related differences in genetic determinants of COVID-19 severity

Researchers at the University of Iowa have identified differences in gene expression levels between African Americans and European Americans that may explain the disproportionately higher rates of coronavirus disease 2019 (COVID-19) cases and related deaths among African Americans.

11 Jun 2020

Nutritional study shows wide range of metabolic responses after eating in healthy adults

Researchers led by King's College London announced today the first published results from PREDICT, the largest ongoing nutritional study of its kind.

11 Jun 2020

Hydroxychloroquine suppresses 'trained immunity'

A new study published on the preprint server medRxiv in June 2020 shows that the drug hydroxychloroquine (HCQ) suppresses a form of immunity called ‘trained immunity,’ with repercussions for its potential use to treat COVID-19.

11 Jun 2020

Baboon could prove to be a relevant model to test Alzheimer's disease interventions

Scientists at Texas Biomedical Research Institute's Southwest National Primate Research Center recently published findings indicating the baboon could prove to be a relevant model to test therapeutics and interventions for neurodegenerative diseases, such as early stage Alzheimer's and related dementias.

10 Jun 2020

BAM15 could be an effective drug for treating obesity and related diseases

A new study offers the first evidence that a protein named BAM15 acts as an energy uncoupler and could be an effective drug for treating obesity and related diseases.

10 Jun 2020

Study: Cigarette smoking can increase the risk of stroke in African Americans

African Americans who smoke are nearly 2.5 times more likely to have a stroke than those who never smoked, while former smokers show a similarly lower risk as never smokers, according to a new study funded by the National Institutes of Health.

10 Jun 2020

Experts discover a rare heart bone in chimpanzees

Experts from the University of Nottingham have discovered that some chimpanzees have a bone in their heart, which could be vital in managing their health and conservation.

10 Jun 2020

Cys-C protein can predict risk of cardiovascular and renal diseases

The glomerular filtration rate (GFR) is normally specified as a measure of kidney function. The GFR is the volume of blood that the kidneys filter per minute (the unit of measurement, in relation to a standardized body surface area, is therefore ml/min/1.73 m2).

10 Jun 2020

Identifying key predictors of mortality in young dialysis patients

The percentage of children and young people who have severe kidney disease and require renal replacement therapy (RRT) is relatively low at approximately 2% .

9 Jun 2020

Empagliflozin reduces CKD progression in type 2 diabetics with cardiovascular disease

Empagliflozin (EMPA), a selective inhibitor of sodium/glucose cotransporter 2 (SGLT2 inhibitors, "gliflozines"), reduces CKD progression in type 2 diabetics (T2D) with cardiovascular disease, presumably by lowering intraglomerular pressure.

9 Jun 2020

COVID-19 produces lung inflammation in non-human primate experiments

A new study published on the online preprint server bioRxiv in June 2020 reports the successful use of three primate species to model the infection, pathogenesis, and clinical features associated with COVID-19. The research provides useful and immediately available models to test new vaccines and treatments.

9 Jun 2020

Heart damage among hospitalized COVID-19 patients linked to higher risk of mortality

Mount Sinai researchers have found that myocardial injury (heart damage) is prevalent among patients hospitalized with COVID-19 and is associated with higher risk of mortality.

8 Jun 2020

Improving detection of SARS-CoV-2 infection among severely ill children

Researchers in the UK have conducted a study showing that children with a severe inflammatory syndrome had high levels of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), despite having tested negative for the virus by polymerase chain reaction (PCR).

8 Jun 2020

Virginia Tech researcher develops new ‘fat burning’ molecule with potential to treat obesity

Obesity affects more than 40 percent of adults in the United States and 13 percent of the global population.

8 Jun 2020

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Cascade Chemistry selected to help speed clinical testing of promising investigational drug for COVID-19

Genetic marker may predispose African Americans to cardiac complications from COVID-19

Common cholesterol-lowering drug linked to improvement in gut microbiota

Vitamin K may offer protective health benefits as we age, study suggests

Study finds link between high levels of dietary AGEs and breast cancer risk

Does COVID-19 injure the placenta of pregnant women?

Race-related differences in genetic determinants of COVID-19 severity

Nutritional study shows wide range of metabolic responses after eating in healthy adults

Hydroxychloroquine suppresses 'trained immunity'

Baboon could prove to be a relevant model to test Alzheimer's disease interventions

BAM15 could be an effective drug for treating obesity and related diseases

Study: Cigarette smoking can increase the risk of stroke in African Americans

Experts discover a rare heart bone in chimpanzees

Cys-C protein can predict risk of cardiovascular and renal diseases

Identifying key predictors of mortality in young dialysis patients

Empagliflozin reduces CKD progression in type 2 diabetics with cardiovascular disease

COVID-19 produces lung inflammation in non-human primate experiments

Heart damage among hospitalized COVID-19 patients linked to higher risk of mortality

Improving detection of SARS-CoV-2 infection among severely ill children

Virginia Tech researcher develops new ‘fat burning’ molecule with potential to treat obesity

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in